Reviews Open access

Mycophenolic acid in Rheumatology: mechanisms of action and severe adverse events

Authors

Section
Reviews
Pages
91-100

Abstract

MPA is clinically administered as morfolinoethyl ester (mycophenolate mofetil, MMF) or, more recently, as a salt (enteric-coated mycophenolate sodium). It is a fermentation product of Penicillium brevicompactum and other analogue fungi, identified by Gosio in 1893 as a weak antibacterial agent; in 1969 Franklin and Cook discovered its capacity to inhibit the inosine mono phosphate dehydrogenase (IMPDH), an enzyme involved in purine nucleotide synthesis (1)...

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.